Garnette D. Draper

Array ( [id] => 4005909 [patent_doc_number] => 05888814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Recombinant host cells encoding TNF proteins' [patent_app_type] => 1 [patent_app_number] => 8/449073 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 17817 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888814.pdf [firstpage_image] =>[orig_patent_app_number] => 449073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3830812 [patent_doc_number] => 05760204 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'DNA encoding murine interleukin-5 receptor' [patent_app_type] => 1 [patent_app_number] => 8/442282 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 10439 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760204.pdf [firstpage_image] =>[orig_patent_app_number] => 442282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774978 [patent_doc_number] => 05807991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Human interleukin-5 receptor' [patent_app_type] => 1 [patent_app_number] => 8/442281 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 10430 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807991.pdf [firstpage_image] =>[orig_patent_app_number] => 442281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7643750 [patent_doc_number] => 06429290 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'OB polypeptides, modified forms and derivatives' [patent_app_type] => B1 [patent_app_number] => 08/438431 [patent_app_country] => US [patent_app_date] => 1995-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 64 [patent_no_of_words] => 55281 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/429/06429290.pdf [firstpage_image] =>[orig_patent_app_number] => 08438431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3722764 [patent_doc_number] => 05681723 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Mutant interleukin 6 with improved biological activity over wild interleukin 6' [patent_app_type] => 1 [patent_app_number] => 8/437680 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2094 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681723.pdf [firstpage_image] =>[orig_patent_app_number] => 437680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939092 [patent_doc_number] => 05872095 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'IL-1 receptor antagonists medicaments' [patent_app_type] => 1 [patent_app_number] => 8/425232 [patent_app_country] => US [patent_app_date] => 1995-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10250 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872095.pdf [firstpage_image] =>[orig_patent_app_number] => 425232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883409 [patent_doc_number] => 05833976 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity' [patent_app_type] => 1 [patent_app_number] => 8/410654 [patent_app_country] => US [patent_app_date] => 1995-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 113 [patent_no_of_words] => 38908 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/833/05833976.pdf [firstpage_image] =>[orig_patent_app_number] => 410654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3838290 [patent_doc_number] => 05744354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Calcineurin inhibitory compounds and anchoring protein to induce IL-2 gene expression' [patent_app_type] => 1 [patent_app_number] => 8/404731 [patent_app_country] => US [patent_app_date] => 1995-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 7148 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744354.pdf [firstpage_image] =>[orig_patent_app_number] => 404731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989557 [patent_doc_number] => 05891680 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12' [patent_app_type] => 1 [patent_app_number] => 8/385335 [patent_app_country] => US [patent_app_date] => 1995-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 7593 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891680.pdf [firstpage_image] =>[orig_patent_app_number] => 385335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380019 [patent_doc_number] => 06294352 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'TNF receptors, TNF binding proteins and DNAs coding for them' [patent_app_type] => 1 [patent_app_number] => 8/383676 [patent_app_country] => US [patent_app_date] => 1995-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 24734 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 63 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294352.pdf [firstpage_image] =>[orig_patent_app_number] => 383676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239393 [patent_doc_number] => 06143866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Tumor necrosis factor (TNF) inhibitor and method for obtaining the same' [patent_app_type] => 1 [patent_app_number] => 8/375242 [patent_app_country] => US [patent_app_date] => 1995-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 69 [patent_no_of_words] => 20958 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143866.pdf [firstpage_image] =>[orig_patent_app_number] => 375242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4207874 [patent_doc_number] => 06077948 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Mediators of chronic allograft rejection (AIF-1) and DNA encoding them' [patent_app_type] => 1 [patent_app_number] => 8/361441 [patent_app_country] => US [patent_app_date] => 1994-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 53 [patent_no_of_words] => 23922 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077948.pdf [firstpage_image] =>[orig_patent_app_number] => 361441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4254257 [patent_doc_number] => 06207802 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Stem cell factor and compositions' [patent_app_type] => 1 [patent_app_number] => 8/336728 [patent_app_country] => US [patent_app_date] => 1994-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 118 [patent_figures_cnt] => 90 [patent_no_of_words] => 53588 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207802.pdf [firstpage_image] =>[orig_patent_app_number] => 336728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659399 [patent_doc_number] => 05648233 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Modified tumor cytotoxic factor (TCF) and DNA encoding such' [patent_app_type] => 1 [patent_app_number] => 8/290937 [patent_app_country] => US [patent_app_date] => 1994-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 8469 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648233.pdf [firstpage_image] =>[orig_patent_app_number] => 290937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290180 [patent_doc_number] => 06268476 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'EPH receptor ligands, and uses related thereto' [patent_app_type] => 1 [patent_app_number] => 8/308814 [patent_app_country] => US [patent_app_date] => 1994-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 35169 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268476.pdf [firstpage_image] =>[orig_patent_app_number] => 308814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915132 [patent_doc_number] => 06001968 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'OB polypeptides, modified forms and compositions' [patent_app_type] => 1 [patent_app_number] => 8/292345 [patent_app_country] => US [patent_app_date] => 1994-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 25 [patent_no_of_words] => 23428 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001968.pdf [firstpage_image] =>[orig_patent_app_number] => 292345 [rel_patent_id] =>[rel_patent_doc_number] =>)